Surgical treatment of benign hypertrophy of the prostate
Lanson, Y.
Presse Medicale 24(32): 1481-1484
1995
ISSN/ISBN: 0755-4982 PMID: 8545347 Document Number: 447252
It has been calculated that 7% of the males living in France over the age of 65% will undergo a surgical procedure for benign prostatic hyperplasia within 5 years. Currently approximately 65000 patients are operated every year. The mean age of the patients is 71.8 years with an incidence much lower than that observed in the United states where the mean age is 66 years. According to the reports of the 87th congress of urology, 10 to 20% of the patients are operated because of urine retention.
Document emailed within 1 workday
Related Documents
Fourcade, R.O.; Lanson, Y.; Teillac, P. 1993: Results of the surgical treatment of benign hypertrophy of the prostate Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 3(5): 823-915Qiu, M-xing.; Wang, D.; Wu, H-min.; Xiong, G-bing.; Chen, Z-xiang. 2007: Dissection of prostate coalesce in treatment of benign prostate hypertrophy with relatively small volume Zhonghua Yi Xue Za Zhi 87(26): 1852-1853
Adriazola Semino, M.; Lozano Ortega, J.L.; García Cobo, E.; Tejeda Báñez, E.; Romero Rodríguez, F. 1992: Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens Archivos Espanoles de Urologia 45(3): 211-213
Martin, A.A.; Clejan, S. 1994: Prostate specific antigen density: a method for differentiating prostate carcinoma from benign prostatic hypertrophy demonstrates ethnic variation Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 146(4): 163-171
Martini, E.; Vaggi, L.; Rucci, A.; Di Clemente, L. 1994: Non-surgical treatment of benign prostatic hypertrophy Journal de Chirurgie 131(10): 445-449
Schulman, C.C. 1993: Surgical treatment of benign prostatic hypertrophy European Urology 23(2): 261
Nakajima, H.; Yui, Y.; Akimoto, M. 1985: Clinical evaluation of surgical treatment for benign prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 31(1): 101-106
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Imai, K.; Kurokawa, K.; Sekihara, T.; Suzuki, T.; Yamanaka, H.; Takahashi, H.; Mashimo, T.; Takahashi, O.; Kitaura, K.; Saruki, K. 1993: Symptoms and signs of benign prostate hypertrophy (BPH) Hinyokika Kiyo. Acta Urologica Japonica 39(1): 15-22
Vicente Rodríguez, J. 1991: Alternatives to transurethral resection of benign hypertrophy of the prostate Archivos Espanoles de Urologia 44(1): 1-7
Verlooy, J.; van Sande, M.; Van Camp, K. 1980: Aldolase activity in benign prostatic hypertrophy and adenocarcinomatous prostate Acta Urologica Belgica 48(1): 65-67
Yamada, S.; Ashizawa, N.; Ushijima, H.; Nakayama, K.; Hayashi, E.; Honda, K. 1987: Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy Journal of Pharmacology and Experimental Therapeutics 242(1): 326-330
Kamimura, N.; Hatakeyama, S.; Kudo, S.; Yoneyama, T.; Hashimoto, Y.; Koie, T.; Yoshikawa, K.; Kawaguchi, T.; Takahashi, S.; Ohyama, C. 2011: Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 57(2): 71-76
Leus, R.; van Sande, M.; Van Camp, K. 1981: Isocitrate dehydrogenase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate Acta Urologica Belgica 49(1): 61-63
Matzkin, H.; Chayen, R.; Goldfarb, H.; Gilad, S.; Braf, Z. 1992: Laboratory monitoring of androgenic activity in benign prostate hypertrophy treated with a 5 alpha-reductase inhibitor Clinical Chemistry 38(7): 1304-1306
Kato, Y.; Nakata, S.; Sato, J.; Mayuzumi, T.; Shimizu, T. 1996: A case of prostate cancer diagnosed one and half year after retropubic prostatectomy for benign prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 42(11): 907-909
Suzuki, K.; Ichinose, Y.; Hashimoto, K.; Matsumoto, K.; Suzuki, T.; Imai, K.; Yamanaka, H. 1990: Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography Hinyokika Kiyo. Acta Urologica Japonica 36(5): 557-560
Romics, I. 2003: Treatment of benign prostatic hypertrophy Orvosi Hetilap 144(45): 2229-2230
Denis, L.; Allegaert, W.; Auvray, P.; Chastel, C.; Desmet, R.; Germeau, F.; Gregoir, W.; Hardy, J.C.; Iarchy, J.; Keuppens, F.; Michielsen, J.P.; Nowé, P.; Petit, R.; Potvliege, M.; Retmann, R.V.; Van Cangh, J.P.; Van Welkenhuyzen, P. 1983: Prostate hypertrophy. Surgical experience in Belgium. Multi-center study of 1,140 patients of 80 years and older Acta Chirurgica Belgica Suppl: 24-28
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420